Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1973 Dec;49(4):588–594. doi: 10.1111/j.1476-5381.1973.tb08534.x

The effect of cannabinoids on intestinal motility and their antinociceptive effect in mice

G B Chesher, C J Dahl, M Everingham, D M Jackson, H Marchant-Williams, G A Starmer
PMCID: PMC1776598  PMID: 4788032

Abstract

1. After oral administration to mice, pethidine, Δ8-tetrahydrocannabinol (THC), Δ9-THC, a cannabis extract and cannabinol had a dose-dependent antinociceptive effect when measured by the hot-plate method. Cannabidiol was inactive at 30 mg/kg. Δ8-THC, Δ9-THC and pethidine did not differ significantly in potency, but Δ9-THC was 6·5 times more active than cannabinol.

2. After oral administration, three different cannabis extracts, Δ8-THC, Δ9-THC and morphine produced dose-dependent depressions of the passage of a charcoal meal in mice. Δ8-THC and Δ9-THC were equipotent and were about five times less potent than morphine. Cannabidiol was inactive up to 30 mg/kg. The effect of the three cannabis extracts on intestinal motility could be accounted for by their Δ9-THC content.

3. The antinociceptive effect of pethidine and the effect of morphine on intestinal motility were antagonized by nalorphine whilst the effects of the cannabis extracts and the pure cannabinoids were not.

4. From these results it is concluded that although cannabis and the narcotics share several common pharmacological properties, the mode of action of each is pharmacologically distinct.

Full text

PDF
588

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bicher H. I., Mechoulam R. Pharmacological effects of two active constituents of marihuana. Arch Int Pharmacodyn Ther. 1968 Mar;172(1):24–31. [PubMed] [Google Scholar]
  2. Buxbaum D. M. Analgesic activity of 9 -tetrahydrocannabinol in the rat and mouse. Psychopharmacologia. 1972;25(3):275–280. doi: 10.1007/BF00422507. [DOI] [PubMed] [Google Scholar]
  3. Dewey W. L., Harris L. S., Kennedy J. S. Some pharmacological and toxicological effects of 1-trans- 8 and 1-trans- 9 -tetrahydrocannabinol in laboratory rodents. Arch Int Pharmacodyn Ther. 1972 Mar;196(1):133–145. [PubMed] [Google Scholar]
  4. Drew W. G., Miller L. L., Wikler A. Effect of 9 -THC on the open-field activity of the rat. Psychopharmacologia. 1972;23(3):289–299. doi: 10.1007/BF00404134. [DOI] [PubMed] [Google Scholar]
  5. Ho B. T., Fritchie G. E., Englert L. F., McIsaac W. M., Idänpän-Heikkilä J. E. Marihuana: importance of the route of administration. J Pharm Pharmacol. 1971 Apr;23(4):309–310. doi: 10.1111/j.2042-7158.1971.tb08666.x. [DOI] [PubMed] [Google Scholar]
  6. Masur J., Martz R. M., Bieniek D., Korte F. Influence of (-) 9 -trans-tetrahydrocannabinol and mescaline on the behavior of rats submitted to food competition situations. Psychopharmacologia. 1971;22(2):187–194. doi: 10.1007/BF00403627. [DOI] [PubMed] [Google Scholar]
  7. Paton W. D., Pertwee R. G. Effect of cannabis and certain of its constituents on pentobarbitone sleeping time and phenazone metabolism. Br J Pharmacol. 1972 Feb;44(2):250–261. [PMC free article] [PubMed] [Google Scholar]
  8. WHITTLE B. A. THE USE OF CHANGES IN CAPILLARY PERMEABILITY IN MICE TO DISTINGUISH BETWEEN NARCOTIC AND NONNARCOTIC ALALGESICS. Br J Pharmacol Chemother. 1964 Apr;22:246–253. doi: 10.1111/j.1476-5381.1964.tb02030.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES